Expectant management of small, recurrent, noninvasive papillary bladder tumors

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 438-441

  Soloway, Mark S ^a   Bruck, Darren S ^a   Kim, Sandy S ^a  

^a Department of Urology ^*

Author keywords

Carcinoma, papillary; Carcinoma, transitional cell; Observation, recurrence, bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER PAPILLOMA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; MORBIDITY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0038152765     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000076621.71247.6c     Document Type: Article

References (15)

1. Greenlee, R. T., Murray, T., Bolden, S. and Wings, P. A.: Cancer statistics, 2000. CA Cancer J Clin, 50: 7, 2000
2. Prout, G. R., Jr., Barton, B. A., Griffin, P. P. and Friedell, G. H. for the National Bladder Cancer Group: Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol, 148: 1413, 1992
3. Herr, H. W.: Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder? BJU Int, 88: 683, 2001
4. Satoh, E., Miyao, N., Tachiki, H. and Fujisawa, Y.: Prediction of muscle invasion of bladder cancer by cystoscopy. Eur Urol, 41: 178, 2002
5. Den Otter, W., Dobrowolski, Z., Bugajski, A., Papla, B., van der Meijden, A. P. M., Koten, J. W. et al: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients. J Urol, 159: 1183, 1998
6. van der Meijden, A. P., Hall, R. R., Kurth, K. H., Bouffioux, C. H. and Sylvester, R.: Phase II trials in Ta, T1 bladder cancer. The marker tumour concept. Br J Urol, 77: 634, 1996
7. Angulo, J. C., Lopez, J. I., Grignon, D. J. and Sanchez-Chapado, M.: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology, 45: 47, 1995
8. Younes, M., Sussman, J. and True, L. D.: The usefulness of the level of muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer, 66: 543, 1990
9. Smith, J. A., Jr., Labasky, R. F., Cockett, A. T. K., Fracchia, J. A., Montie, J. E. and Rowland, R. G.: Bladder Cancer Clinical Guidelines Panel summary report on the management of non-muscle invasive bladder cancer (stages Ta, T1 and TIS). J Urol, 162: 1697, 1999
10. Holmäng, S., Andius, P., Hedelin, H., Wester, K., Busch, C. and Johansson, S. L.: Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol, 165: 1124, 2001
11. Millán-Rodríguez, F., Chéchile-Toniolo, G., Salvador-Bayarri, J., Palou, J., Algaba, F. and Vicente-Rodríguez, J.: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol, 164: 680, 2000
12. Soloway, M. S.: Flexible cystourethroscopy: alternative to rigid instruments for evaluation of lower urinary tract. Urology, 25: 472, 1985
13. Young, M. J. and Soloway, M. S.: Office evaluation and management of bladder neoplasms. Urol Clin North Am, 25: 603, 1998
14. Herr, H. W.: Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors. J Urol, 144: 1365, 1990
15. Beaghler, M. and Grasso, M., 3rd: Flexible cystoscopic bladder biopsies: a technique for outpatient evaluation of the lower urinary tract urothelium. Urology, 44: 756, 1994